nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—EPHA2—pulmonary artery—Behcet's disease	0.0338	0.0536	CbGeAlD
Regorafenib—FLT4—endothelium—Behcet's disease	0.0128	0.0204	CbGeAlD
Regorafenib—TEK—artery—Behcet's disease	0.0122	0.0194	CbGeAlD
Regorafenib—FLT4—blood vessel—Behcet's disease	0.0118	0.0188	CbGeAlD
Regorafenib—FLT1—artery—Behcet's disease	0.0118	0.0188	CbGeAlD
Regorafenib—DDR2—eye—Behcet's disease	0.0103	0.0164	CbGeAlD
Regorafenib—TEK—endothelium—Behcet's disease	0.0103	0.0164	CbGeAlD
Regorafenib—DDR2—retina—Behcet's disease	0.0102	0.0163	CbGeAlD
Regorafenib—KDR—artery—Behcet's disease	0.00998	0.0159	CbGeAlD
Regorafenib—FLT1—endothelium—Behcet's disease	0.00997	0.0158	CbGeAlD
Regorafenib—EPHA2—blood vessel—Behcet's disease	0.00975	0.0155	CbGeAlD
Regorafenib—TEK—blood vessel—Behcet's disease	0.00951	0.0151	CbGeAlD
Regorafenib—FLT1—blood vessel—Behcet's disease	0.00919	0.0146	CbGeAlD
Regorafenib—NTRK1—midbrain—Behcet's disease	0.0091	0.0145	CbGeAlD
Regorafenib—DDR2—skin of body—Behcet's disease	0.00899	0.0143	CbGeAlD
Regorafenib—KDR—endothelium—Behcet's disease	0.00843	0.0134	CbGeAlD
Regorafenib—FGFR2—mouth—Behcet's disease	0.0083	0.0132	CbGeAlD
Regorafenib—DDR2—mammalian vulva—Behcet's disease	0.00819	0.013	CbGeAlD
Regorafenib—KDR—blood vessel—Behcet's disease	0.00777	0.0123	CbGeAlD
Regorafenib—KIT—endothelium—Behcet's disease	0.00747	0.0119	CbGeAlD
Regorafenib—EPHX2—eye—Behcet's disease	0.00698	0.0111	CbGeAlD
Regorafenib—EPHX2—retina—Behcet's disease	0.00691	0.011	CbGeAlD
Regorafenib—KIT—blood vessel—Behcet's disease	0.00689	0.0109	CbGeAlD
Regorafenib—PDGFRB—blood vessel—Behcet's disease	0.00673	0.0107	CbGeAlD
Regorafenib—DDR2—spinal cord—Behcet's disease	0.0066	0.0105	CbGeAlD
Regorafenib—FLT4—eye—Behcet's disease	0.00629	0.01	CbGeAlD
Regorafenib—KIT—mouth—Behcet's disease	0.00576	0.00916	CbGeAlD
Regorafenib—DDR2—nervous system—Behcet's disease	0.00556	0.00883	CbGeAlD
Regorafenib—EPHX2—mammalian vulva—Behcet's disease	0.00554	0.0088	CbGeAlD
Regorafenib—FGFR2—brainstem—Behcet's disease	0.00542	0.00862	CbGeAlD
Regorafenib—DDR2—central nervous system—Behcet's disease	0.00535	0.0085	CbGeAlD
Regorafenib—FGFR2—eye—Behcet's disease	0.00528	0.00839	CbGeAlD
Regorafenib—MAPK11—nervous system—Behcet's disease	0.00527	0.00837	CbGeAlD
Regorafenib—MAPK11—central nervous system—Behcet's disease	0.00507	0.00806	CbGeAlD
Regorafenib—RAF1—brainstem—Behcet's disease	0.005	0.00794	CbGeAlD
Regorafenib—FGFR1—mammalian vulva—Behcet's disease	0.00493	0.00783	CbGeAlD
Regorafenib—FLT1—eye—Behcet's disease	0.00489	0.00777	CbGeAlD
Regorafenib—RAF1—eye—Behcet's disease	0.00486	0.00773	CbGeAlD
Regorafenib—FLT1—retina—Behcet's disease	0.00485	0.0077	CbGeAlD
Regorafenib—BRAF—midbrain—Behcet's disease	0.00478	0.00759	CbGeAlD
Regorafenib—FGFR1—cardiac atrium—Behcet's disease	0.00472	0.0075	CbGeAlD
Regorafenib—FGFR2—skin of body—Behcet's disease	0.00459	0.0073	CbGeAlD
Regorafenib—FGFR1—medulla oblongata—Behcet's disease	0.00445	0.00707	CbGeAlD
Regorafenib—DDR2—brain—Behcet's disease	0.00425	0.00675	CbGeAlD
Regorafenib—RAF1—skin of body—Behcet's disease	0.00423	0.00672	CbGeAlD
Regorafenib—KDR—eye—Behcet's disease	0.00414	0.00657	CbGeAlD
Regorafenib—EPHA2—mammalian vulva—Behcet's disease	0.00412	0.00654	CbGeAlD
Regorafenib—KDR—retina—Behcet's disease	0.0041	0.00651	CbGeAlD
Regorafenib—FGFR1—midbrain—Behcet's disease	0.00406	0.00646	CbGeAlD
Regorafenib—MAPK11—brain—Behcet's disease	0.00403	0.0064	CbGeAlD
Regorafenib—RET—medulla oblongata—Behcet's disease	0.00398	0.00632	CbGeAlD
Regorafenib—FGFR1—spinal cord—Behcet's disease	0.00396	0.0063	CbGeAlD
Regorafenib—EPHA2—cardiac atrium—Behcet's disease	0.00394	0.00626	CbGeAlD
Regorafenib—FLT1—mammalian vulva—Behcet's disease	0.00388	0.00617	CbGeAlD
Regorafenib—RAF1—mammalian vulva—Behcet's disease	0.00386	0.00613	CbGeAlD
Regorafenib—TEK—cardiac atrium—Behcet's disease	0.00384	0.00611	CbGeAlD
Regorafenib—KIT—brainstem—Behcet's disease	0.00376	0.00598	CbGeAlD
Regorafenib—FLT1—cardiac atrium—Behcet's disease	0.00372	0.00591	CbGeAlD
Regorafenib—RAF1—cardiac atrium—Behcet's disease	0.0037	0.00587	CbGeAlD
Regorafenib—RET—midbrain—Behcet's disease	0.00364	0.00578	CbGeAlD
Regorafenib—TEK—medulla oblongata—Behcet's disease	0.00362	0.00576	CbGeAlD
Regorafenib—PDGFRB—eye—Behcet's disease	0.00358	0.00569	CbGeAlD
Regorafenib—RET—spinal cord—Behcet's disease	0.00355	0.00564	CbGeAlD
Regorafenib—FLT1—medulla oblongata—Behcet's disease	0.0035	0.00557	CbGeAlD
Regorafenib—RAF1—medulla oblongata—Behcet's disease	0.00348	0.00554	CbGeAlD
Regorafenib—FGFR2—spinal cord—Behcet's disease	0.00337	0.00536	CbGeAlD
Regorafenib—TEK—midbrain—Behcet's disease	0.00331	0.00526	CbGeAlD
Regorafenib—KDR—mammalian vulva—Behcet's disease	0.00328	0.00521	CbGeAlD
Regorafenib—ABL1—brainstem—Behcet's disease	0.00328	0.00521	CbGeAlD
Regorafenib—TEK—spinal cord—Behcet's disease	0.00323	0.00514	CbGeAlD
Regorafenib—FLT1—midbrain—Behcet's disease	0.0032	0.00509	CbGeAlD
Regorafenib—ABL1—eye—Behcet's disease	0.00319	0.00507	CbGeAlD
Regorafenib—KIT—skin of body—Behcet's disease	0.00319	0.00507	CbGeAlD
Regorafenib—RAF1—midbrain—Behcet's disease	0.00318	0.00506	CbGeAlD
Regorafenib—ABL1—retina—Behcet's disease	0.00316	0.00502	CbGeAlD
Regorafenib—KDR—cardiac atrium—Behcet's disease	0.00314	0.00499	CbGeAlD
Regorafenib—FLT1—spinal cord—Behcet's disease	0.00312	0.00497	CbGeAlD
Regorafenib—PDGFRB—skin of body—Behcet's disease	0.00311	0.00495	CbGeAlD
Regorafenib—RAF1—spinal cord—Behcet's disease	0.00311	0.00494	CbGeAlD
Regorafenib—BRAF—brain—Behcet's disease	0.003	0.00477	CbGeAlD
Regorafenib—RET—nervous system—Behcet's disease	0.00299	0.00475	CbGeAlD
Regorafenib—KDR—medulla oblongata—Behcet's disease	0.00296	0.00471	CbGeAlD
Regorafenib—PDGFRA—spinal cord—Behcet's disease	0.00293	0.00465	CbGeAlD
Regorafenib—KIT—mammalian vulva—Behcet's disease	0.00291	0.00462	CbGeAlD
Regorafenib—RET—central nervous system—Behcet's disease	0.00288	0.00457	CbGeAlD
Regorafenib—EPHX2—brain—Behcet's disease	0.00287	0.00456	CbGeAlD
Regorafenib—FGFR2—nervous system—Behcet's disease	0.00284	0.00451	CbGeAlD
Regorafenib—PDGFRB—mammalian vulva—Behcet's disease	0.00284	0.00451	CbGeAlD
Regorafenib—EPHA2—nervous system—Behcet's disease	0.00279	0.00444	CbGeAlD
Regorafenib—ABL1—skin of body—Behcet's disease	0.00278	0.00441	CbGeAlD
Regorafenib—FGFR2—central nervous system—Behcet's disease	0.00273	0.00435	CbGeAlD
Regorafenib—TEK—nervous system—Behcet's disease	0.00272	0.00433	CbGeAlD
Regorafenib—PDGFRB—cardiac atrium—Behcet's disease	0.00272	0.00432	CbGeAlD
Regorafenib—KDR—midbrain—Behcet's disease	0.00271	0.0043	CbGeAlD
Regorafenib—EPHA2—central nervous system—Behcet's disease	0.00269	0.00427	CbGeAlD
Regorafenib—KDR—spinal cord—Behcet's disease	0.00264	0.0042	CbGeAlD
Regorafenib—FLT1—nervous system—Behcet's disease	0.00263	0.00418	CbGeAlD
Regorafenib—KIT—medulla oblongata—Behcet's disease	0.00263	0.00417	CbGeAlD
Regorafenib—TEK—central nervous system—Behcet's disease	0.00262	0.00417	CbGeAlD
Regorafenib—RAF1—nervous system—Behcet's disease	0.00262	0.00416	CbGeAlD
Regorafenib—FLT4—brain—Behcet's disease	0.00259	0.00411	CbGeAlD
Regorafenib—PDGFRB—medulla oblongata—Behcet's disease	0.00256	0.00407	CbGeAlD
Regorafenib—FGFR1—brain—Behcet's disease	0.00255	0.00406	CbGeAlD
Regorafenib—FLT1—central nervous system—Behcet's disease	0.00253	0.00403	CbGeAlD
Regorafenib—ABL1—mammalian vulva—Behcet's disease	0.00253	0.00402	CbGeAlD
Regorafenib—RAF1—central nervous system—Behcet's disease	0.00252	0.004	CbGeAlD
Regorafenib—PDGFRA—nervous system—Behcet's disease	0.00247	0.00392	CbGeAlD
Regorafenib—ABL1—cardiac atrium—Behcet's disease	0.00242	0.00385	CbGeAlD
Regorafenib—KIT—midbrain—Behcet's disease	0.0024	0.00381	CbGeAlD
Regorafenib—PDGFRA—central nervous system—Behcet's disease	0.00238	0.00377	CbGeAlD
Regorafenib—PDGFRB—midbrain—Behcet's disease	0.00234	0.00372	CbGeAlD
Regorafenib—KIT—spinal cord—Behcet's disease	0.00234	0.00372	CbGeAlD
Regorafenib—PDGFRB—spinal cord—Behcet's disease	0.00229	0.00363	CbGeAlD
Regorafenib—ABL1—medulla oblongata—Behcet's disease	0.00229	0.00363	CbGeAlD
Regorafenib—RET—brain—Behcet's disease	0.00229	0.00363	CbGeAlD
Regorafenib—KDR—nervous system—Behcet's disease	0.00223	0.00354	CbGeAlD
Regorafenib—FGFR2—brain—Behcet's disease	0.00217	0.00345	CbGeAlD
Regorafenib—KDR—central nervous system—Behcet's disease	0.00214	0.00341	CbGeAlD
Regorafenib—EPHA2—brain—Behcet's disease	0.00213	0.00339	CbGeAlD
Regorafenib—ABL1—midbrain—Behcet's disease	0.00209	0.00332	CbGeAlD
Regorafenib—TEK—brain—Behcet's disease	0.00208	0.00331	CbGeAlD
Regorafenib—ABL1—spinal cord—Behcet's disease	0.00204	0.00324	CbGeAlD
Regorafenib—FLT1—brain—Behcet's disease	0.00201	0.0032	CbGeAlD
Regorafenib—RAF1—brain—Behcet's disease	0.002	0.00318	CbGeAlD
Regorafenib—KIT—nervous system—Behcet's disease	0.00197	0.00313	CbGeAlD
Regorafenib—PDGFRB—nervous system—Behcet's disease	0.00193	0.00306	CbGeAlD
Regorafenib—KIT—central nervous system—Behcet's disease	0.0019	0.00302	CbGeAlD
Regorafenib—PDGFRA—brain—Behcet's disease	0.00189	0.003	CbGeAlD
Regorafenib—ABCB1—blood vessel—Behcet's disease	0.00186	0.00296	CbGeAlD
Regorafenib—PDGFRB—central nervous system—Behcet's disease	0.00185	0.00295	CbGeAlD
Regorafenib—ABL1—nervous system—Behcet's disease	0.00172	0.00273	CbGeAlD
Regorafenib—KDR—brain—Behcet's disease	0.0017	0.0027	CbGeAlD
Regorafenib—ABL1—central nervous system—Behcet's disease	0.00165	0.00263	CbGeAlD
Regorafenib—CYP2B6—skin of body—Behcet's disease	0.00161	0.00257	CbGeAlD
Regorafenib—ABCG2—mammalian vulva—Behcet's disease	0.0016	0.00254	CbGeAlD
Regorafenib—KIT—brain—Behcet's disease	0.00151	0.0024	CbGeAlD
Regorafenib—PDGFRB—brain—Behcet's disease	0.00147	0.00234	CbGeAlD
Regorafenib—ABCG2—medulla oblongata—Behcet's disease	0.00144	0.00229	CbGeAlD
Regorafenib—ABCG2—midbrain—Behcet's disease	0.00132	0.00209	CbGeAlD
Regorafenib—ABL1—brain—Behcet's disease	0.00131	0.00209	CbGeAlD
Regorafenib—ABCG2—spinal cord—Behcet's disease	0.00129	0.00204	CbGeAlD
Regorafenib—CYP2B6—nervous system—Behcet's disease	0.000999	0.00159	CbGeAlD
Regorafenib—ABCB1—retina—Behcet's disease	0.000983	0.00156	CbGeAlD
Regorafenib—CYP2B6—central nervous system—Behcet's disease	0.000962	0.00153	CbGeAlD
Regorafenib—CYP2C8—brain—Behcet's disease	0.000851	0.00135	CbGeAlD
Regorafenib—ABCG2—brain—Behcet's disease	0.000828	0.00132	CbGeAlD
Regorafenib—ABCB1—mammalian vulva—Behcet's disease	0.000787	0.00125	CbGeAlD
Regorafenib—CYP2B6—brain—Behcet's disease	0.000764	0.00121	CbGeAlD
Regorafenib—CYP3A4—nervous system—Behcet's disease	0.000754	0.0012	CbGeAlD
Regorafenib—CYP3A4—central nervous system—Behcet's disease	0.000726	0.00115	CbGeAlD
Regorafenib—ABCB1—medulla oblongata—Behcet's disease	0.000711	0.00113	CbGeAlD
Regorafenib—ABCB1—midbrain—Behcet's disease	0.000649	0.00103	CbGeAlD
Regorafenib—ABCB1—spinal cord—Behcet's disease	0.000634	0.00101	CbGeAlD
Regorafenib—ABCB1—nervous system—Behcet's disease	0.000534	0.000848	CbGeAlD
Regorafenib—ABCB1—central nervous system—Behcet's disease	0.000514	0.000817	CbGeAlD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000449	0.00121	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CTLA4—Behcet's disease	0.000449	0.00121	CbGpPWpGaD
Regorafenib—RAF1—TNF alpha Signaling Pathway—TNF—Behcet's disease	0.000449	0.00121	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ERAP1—Behcet's disease	0.000443	0.00119	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CTLA4—Behcet's disease	0.000441	0.00119	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—ITGB2—Behcet's disease	0.000439	0.00118	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—APOB—Behcet's disease	0.000437	0.00118	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—ITGAL—Behcet's disease	0.000431	0.00116	CbGpPWpGaD
Regorafenib—KIT—Immune System—ITGB2—Behcet's disease	0.000431	0.00116	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CTLA4—Behcet's disease	0.000419	0.00113	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CTLA4—Behcet's disease	0.000418	0.00113	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—ITGB2—Behcet's disease	0.000409	0.0011	CbGpPWpGaD
Regorafenib—ABCB1—brain—Behcet's disease	0.000408	0.000649	CbGeAlD
Regorafenib—PDGFRA—Immune System—ITGB2—Behcet's disease	0.000408	0.0011	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—CXCL8—Behcet's disease	0.000405	0.00109	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—TNF—Behcet's disease	0.000401	0.00108	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCR1—Behcet's disease	0.0004	0.00108	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—ITGAL—Behcet's disease	0.000396	0.00107	CbGpPWpGaD
Regorafenib—KIT—Immune System—ITGAL—Behcet's disease	0.000389	0.00105	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCR1—Behcet's disease	0.000378	0.00102	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000378	0.00102	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CCR1—Behcet's disease	0.000377	0.00102	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—HLA-B—Behcet's disease	0.000377	0.00102	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CTLA4—Behcet's disease	0.000376	0.00101	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000374	0.00101	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—ITGAL—Behcet's disease	0.000369	0.000995	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—ITGAL—Behcet's disease	0.000368	0.000993	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—ITGB2—Behcet's disease	0.000368	0.000992	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—APOB—Behcet's disease	0.000359	0.000969	CbGpPWpGaD
Regorafenib—ABL1—Immune System—ITGB2—Behcet's disease	0.000358	0.000966	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TNF—Behcet's disease	0.000346	0.000934	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—HLA-B—Behcet's disease	0.000346	0.000933	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—APOA1—Behcet's disease	0.000346	0.000932	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000344	0.000927	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—HLA-B—Behcet's disease	0.00034	0.000917	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—APOB—Behcet's disease	0.000339	0.000915	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CTLA4—Behcet's disease	0.000335	0.000905	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HLA-B—Behcet's disease	0.000332	0.000896	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—ITGAL—Behcet's disease	0.000332	0.000894	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ITGB2—Behcet's disease	0.000328	0.000884	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HLA-B—Behcet's disease	0.000326	0.00088	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCR1—Behcet's disease	0.000325	0.000877	CbGpPWpGaD
Regorafenib—ABL1—Immune System—ITGAL—Behcet's disease	0.000323	0.000872	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—HLA-B—Behcet's disease	0.000323	0.00087	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCR1—Behcet's disease	0.000322	0.000868	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—HLA-B—Behcet's disease	0.000322	0.000868	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000313	0.000843	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000312	0.000841	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TNF—Behcet's disease	0.000311	0.000839	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—APOB—Behcet's disease	0.00031	0.000836	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HLA-B—Behcet's disease	0.00031	0.000835	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HLA-B—Behcet's disease	0.000309	0.000833	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCR1—Behcet's disease	0.000298	0.000805	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CTLA4—Behcet's disease	0.000297	0.0008	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ITGAL—Behcet's disease	0.000296	0.000797	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCR1—Behcet's disease	0.000293	0.00079	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00029	0.000783	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—HLA-B—Behcet's disease	0.00029	0.000782	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—APOA1—Behcet's disease	0.000284	0.000767	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—HLA-B—Behcet's disease	0.000282	0.000762	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TNF—Behcet's disease	0.000282	0.00076	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HLA-B—Behcet's disease	0.000278	0.000751	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCR1—Behcet's disease	0.000278	0.00075	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCR1—Behcet's disease	0.000277	0.000748	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TNF—Behcet's disease	0.000277	0.000748	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000274	0.000738	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CTLA4—Behcet's disease	0.000272	0.000735	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—ICAM1—Behcet's disease	0.00027	0.000728	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000268	0.000724	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—APOA1—Behcet's disease	0.000268	0.000724	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—APOB—Behcet's disease	0.000268	0.000723	CbGpPWpGaD
Regorafenib—KIT—Immune System—CTLA4—Behcet's disease	0.000268	0.000722	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—ICAM1—Behcet's disease	0.000265	0.000715	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—NOS3—Behcet's disease	0.000262	0.000706	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—HLA-B—Behcet's disease	0.000258	0.000697	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CTLA4—Behcet's disease	0.000254	0.000685	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CTLA4—Behcet's disease	0.000253	0.000683	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—ICAM1—Behcet's disease	0.000252	0.000679	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—ICAM1—Behcet's disease	0.000251	0.000677	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.00025	0.000675	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCR1—Behcet's disease	0.00025	0.000674	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HLA-B—Behcet's disease	0.000248	0.000669	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—APOA1—Behcet's disease	0.000245	0.000662	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000239	0.000645	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000234	0.000632	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00023	0.000619	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CTLA4—Behcet's disease	0.000228	0.000616	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—ICAM1—Behcet's disease	0.000226	0.00061	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—SERPINE1—Behcet's disease	0.000226	0.000609	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR1—Behcet's disease	0.000223	0.000601	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CTLA4—Behcet's disease	0.000222	0.0006	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-B—Behcet's disease	0.00022	0.000592	CbGpPWpGaD
Regorafenib—BRAF—Disease—APOB—Behcet's disease	0.000217	0.000585	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—NOS3—Behcet's disease	0.000215	0.000581	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—SERPINE1—Behcet's disease	0.000213	0.000574	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000212	0.000573	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—APOA1—Behcet's disease	0.000212	0.000572	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CTLA4—Behcet's disease	0.000203	0.000549	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—NOS3—Behcet's disease	0.000203	0.000548	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-B—Behcet's disease	0.000202	0.000544	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—ICAM1—Behcet's disease	0.000202	0.000544	CbGpPWpGaD
Regorafenib—FGFR2—Disease—APOB—Behcet's disease	0.000201	0.000542	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TNF—Behcet's disease	0.000199	0.000536	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-B—Behcet's disease	0.000198	0.000534	CbGpPWpGaD
Regorafenib—KIT—Disease—APOB—Behcet's disease	0.000198	0.000533	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—SERPINE1—Behcet's disease	0.000195	0.000525	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CXCL8—Behcet's disease	0.000191	0.000516	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—APOB—Behcet's disease	0.000189	0.000509	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-B—Behcet's disease	0.000188	0.000507	CbGpPWpGaD
Regorafenib—FGFR1—Disease—APOB—Behcet's disease	0.000187	0.000506	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-B—Behcet's disease	0.000187	0.000505	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—APOB—Behcet's disease	0.000187	0.000504	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—NOS3—Behcet's disease	0.000186	0.000502	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000185	0.0005	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—APOB—Behcet's disease	0.000178	0.000481	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—ICAM1—Behcet's disease	0.000178	0.000481	CbGpPWpGaD
Regorafenib—BRAF—Disease—APOA1—Behcet's disease	0.000172	0.000463	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—Behcet's disease	0.000171	0.000461	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-B—Behcet's disease	0.000169	0.000455	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—APOB—Behcet's disease	0.000168	0.000454	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SERPINE1—Behcet's disease	0.000168	0.000454	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-B—Behcet's disease	0.000164	0.000444	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—ICAM1—Behcet's disease	0.000164	0.000442	CbGpPWpGaD
Regorafenib—KIT—Immune System—ICAM1—Behcet's disease	0.000161	0.000434	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—NOS3—Behcet's disease	0.000161	0.000434	CbGpPWpGaD
Regorafenib—FGFR2—Disease—APOA1—Behcet's disease	0.000159	0.000429	CbGpPWpGaD
Regorafenib—KIT—Disease—APOA1—Behcet's disease	0.000156	0.000422	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—APOB—Behcet's disease	0.000153	0.000414	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000153	0.000412	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—ICAM1—Behcet's disease	0.000153	0.000412	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—ICAM1—Behcet's disease	0.000152	0.000411	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—APOB—Behcet's disease	0.000152	0.00041	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-B—Behcet's disease	0.00015	0.000406	CbGpPWpGaD
Regorafenib—RAF1—Disease—APOB—Behcet's disease	0.00015	0.000405	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—APOA1—Behcet's disease	0.000149	0.000403	CbGpPWpGaD
Regorafenib—FGFR1—Disease—APOA1—Behcet's disease	0.000148	0.0004	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—SERPINE1—Behcet's disease	0.000148	0.0004	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—APOA1—Behcet's disease	0.000148	0.000399	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—Behcet's disease	0.000146	0.000394	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CXCL8—Behcet's disease	0.000143	0.000385	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—APOA1—Behcet's disease	0.000141	0.000381	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—APOB—Behcet's disease	0.000141	0.00038	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—APOB—Behcet's disease	0.000138	0.000373	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—ICAM1—Behcet's disease	0.000137	0.00037	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000136	0.000368	CbGpPWpGaD
Regorafenib—BRAF—Disease—SERPINE1—Behcet's disease	0.000136	0.000368	CbGpPWpGaD
Regorafenib—ABL1—Immune System—ICAM1—Behcet's disease	0.000134	0.00036	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—APOA1—Behcet's disease	0.000133	0.000359	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CAT—Behcet's disease	0.000133	0.000359	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CAT—Behcet's disease	0.000133	0.000359	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—APOB—Behcet's disease	0.000131	0.000354	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—APOB—Behcet's disease	0.000131	0.000353	CbGpPWpGaD
Regorafenib—BRAF—Disease—NOS3—Behcet's disease	0.00013	0.000351	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—APOB—Behcet's disease	0.000129	0.000349	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—APOB—Behcet's disease	0.000129	0.000349	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—Behcet's disease	0.000128	0.000345	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000127	0.000341	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SERPINE1—Behcet's disease	0.000126	0.000341	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000124	0.000335	CbGpPWpGaD
Regorafenib—KIT—Disease—SERPINE1—Behcet's disease	0.000124	0.000335	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ICAM1—Behcet's disease	0.000122	0.00033	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—APOA1—Behcet's disease	0.000121	0.000327	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000121	0.000326	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NOS3—Behcet's disease	0.000121	0.000325	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—APOA1—Behcet's disease	0.00012	0.000324	CbGpPWpGaD
Regorafenib—RAF1—Disease—APOA1—Behcet's disease	0.000119	0.00032	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SERPINE1—Behcet's disease	0.000119	0.00032	CbGpPWpGaD
Regorafenib—KIT—Disease—NOS3—Behcet's disease	0.000118	0.000319	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000118	0.000318	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—APOB—Behcet's disease	0.000118	0.000318	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SERPINE1—Behcet's disease	0.000118	0.000318	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SERPINE1—Behcet's disease	0.000117	0.000317	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—Behcet's disease	0.000117	0.000316	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NOS3—Behcet's disease	0.000113	0.000305	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CAT—Behcet's disease	0.000113	0.000305	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NOS3—Behcet's disease	0.000112	0.000303	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NOS3—Behcet's disease	0.000112	0.000302	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SERPINE1—Behcet's disease	0.000112	0.000302	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—APOA1—Behcet's disease	0.000111	0.000301	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—APOB—Behcet's disease	0.00011	0.000296	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—APOA1—Behcet's disease	0.000109	0.000295	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000108	0.000291	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NOS3—Behcet's disease	0.000107	0.000288	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SERPINE1—Behcet's disease	0.000106	0.000285	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—APOB—Behcet's disease	0.000105	0.000284	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—APOA1—Behcet's disease	0.000104	0.00028	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—APOA1—Behcet's disease	0.000104	0.000279	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—APOA1—Behcet's disease	0.000102	0.000276	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—APOA1—Behcet's disease	0.000102	0.000276	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NOS3—Behcet's disease	0.000101	0.000272	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CXCL8—Behcet's disease	0.0001	0.000271	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.0001	0.00027	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	9.84e-05	0.000265	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SERPINE1—Behcet's disease	9.63e-05	0.00026	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SERPINE1—Behcet's disease	9.54e-05	0.000257	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CXCL8—Behcet's disease	9.49e-05	0.000256	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CXCL8—Behcet's disease	9.47e-05	0.000255	CbGpPWpGaD
Regorafenib—RAF1—Disease—SERPINE1—Behcet's disease	9.43e-05	0.000254	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—APOA1—Behcet's disease	9.33e-05	0.000252	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NOS3—Behcet's disease	9.2e-05	0.000248	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NOS3—Behcet's disease	9.11e-05	0.000246	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS3—Behcet's disease	9e-05	0.000243	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SERPINE1—Behcet's disease	8.84e-05	0.000239	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SERPINE1—Behcet's disease	8.69e-05	0.000234	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—APOA1—Behcet's disease	8.68e-05	0.000234	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NOS3—Behcet's disease	8.44e-05	0.000228	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—APOA1—Behcet's disease	8.32e-05	0.000224	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NOS3—Behcet's disease	8.29e-05	0.000224	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CAT—Behcet's disease	8.28e-05	0.000223	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SERPINE1—Behcet's disease	8.24e-05	0.000222	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SERPINE1—Behcet's disease	8.22e-05	0.000222	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—Behcet's disease	8.16e-05	0.00022	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—Behcet's disease	8.08e-05	0.000218	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APOB—Behcet's disease	8.04e-05	0.000217	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOS3—Behcet's disease	7.87e-05	0.000212	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOS3—Behcet's disease	7.85e-05	0.000212	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NOS3—Behcet's disease	7.75e-05	0.000209	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NOS3—Behcet's disease	7.75e-05	0.000209	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—Behcet's disease	7.49e-05	0.000202	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SERPINE1—Behcet's disease	7.41e-05	0.0002	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—Behcet's disease	7.36e-05	0.000198	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOS3—Behcet's disease	7.07e-05	0.000191	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAT—Behcet's disease	7.01e-05	0.000189	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—Behcet's disease	6.98e-05	0.000188	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—Behcet's disease	6.96e-05	0.000188	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOB—Behcet's disease	6.81e-05	0.000184	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SERPINE1—Behcet's disease	6.6e-05	0.000178	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NOS3—Behcet's disease	6.58e-05	0.000177	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APOA1—Behcet's disease	6.36e-05	0.000172	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOS3—Behcet's disease	6.3e-05	0.00017	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—Behcet's disease	6.27e-05	0.000169	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAT—Behcet's disease	6.26e-05	0.000169	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAT—Behcet's disease	6.11e-05	0.000165	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOB—Behcet's disease	6.07e-05	0.000164	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOB—Behcet's disease	5.93e-05	0.00016	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAT—Behcet's disease	5.71e-05	0.000154	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—Behcet's disease	5.59e-05	0.000151	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOB—Behcet's disease	5.54e-05	0.000149	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOA1—Behcet's disease	5.38e-05	0.000145	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—Behcet's disease	4.82e-05	0.00013	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOA1—Behcet's disease	4.81e-05	0.00013	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOA1—Behcet's disease	4.69e-05	0.000127	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOA1—Behcet's disease	4.38e-05	0.000118	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—Behcet's disease	4.08e-05	0.00011	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAT—Behcet's disease	3.76e-05	0.000101	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOB—Behcet's disease	3.65e-05	9.85e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—Behcet's disease	3.64e-05	9.82e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—Behcet's disease	3.56e-05	9.59e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—Behcet's disease	3.32e-05	8.96e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOA1—Behcet's disease	2.89e-05	7.8e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—Behcet's disease	2.19e-05	5.91e-05	CbGpPWpGaD
